Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by DexterMorganon Nov 04, 2021 4:11pm
189 Views
Post# 34088710

RE:Sirona investors only have hope left

RE:Sirona investors only have hope leftYes, its the three legged stool of fundamentals for a successful stock play and adding value to the company overall.  Technology, Management and Funding.  All three are certainly in question.  Technology is showing promise and is starting to prove its value.  Funding is always a question mark.  Managment however is woefully missing from this company where most smart investors will steer clear.  If there is anything that can and needs to be done, right now, is change there board and management.  They are not ideally suited at this stage to this role(s) and need an experienced team to take it forward.  Its a no-brainer however this team seems to lack self awareness and to recognize that they are need of a new fresh mgt team to take this to the next level.  They are way past this need but NOW would be a good time.  Out with the old, in with the new. With this, the technology will continue and funding will hopefully follow in kind.
<< Previous
Bullboard Posts
Next >>